Adempas Tablets and Antihemophilic Factor (Recombinant [Pegylated])
Determining the interaction of Adempas Tablets and Antihemophilic Factor (Recombinant [Pegylated]) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Adempas Tablets-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Adempas Tablets-Antihemophilic Factor (Recombinant) (Advate)
- Adempas Tablets-Antihemophilic Factor (Recombinant) (Afstyla)
- Adempas Tablets-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Adempas Tablets-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Antihemophilic Factor (Recombinant [Pegylated])-Adenocard
- Antihemophilic Factor (Recombinant [Pegylated])-Adenoscan
- Antihemophilic Factor (Recombinant [Pegylated])-Adenosine
- Antihemophilic Factor (Recombinant [Pegylated])-Adenosine Intravenous
- Antihemophilic Factor (Recombinant [Pegylated])-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Antihemophilic Factor (Recombinant [Pegylated])-Adenovirus Vaccine